Jeffrey N. Bruce

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Outcomes of Combined Microsurgery and Stereotactic Radiosurgery for Motor Strip Brain Metastases

  World Neurosurgery · 2026-06-01

• cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes

  Journal of Neuro-Oncology · 2026-05-01

• 59831 Convection-Enhanced Delivery of Topotecan Induces IL-1β-Associated Inflammation in Glioblastoma

  Neurosurgery · 2026-03-26

• Electrophysiologically Targeted Biopsies Reveal the Transcriptional Landscape of Focal Epilepsy

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-03-10

• A therapeutic role for a regulatory GLUT1–associated lncRNA in GLUT1-deficient mice

  Journal of Clinical Investigation · 2026-03-05

• Prospective Observational Study of 118 Clinically Nonfunctioning Pituitary Adenomas

  Endocrine Practice · 2025-12-17

• Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S1 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S7 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Supplementary Figures S1-S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S4 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

  2025-12-11

• Supplementary Figures S1-S6 from <i>MGMT</i> Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas

  2025-11-25

• Supplementary Tables S1-S3 from <i>MGMT</i> Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas

  2025-11-25

• Management of Incidentally Discovered Pineal Cyst on CT and MRI: Recommendations from the ACR Incidental Findings Committee

  Journal of the American College of Radiology · 2025-11-10 · 2 citations

• Tumor intrinsic mechanisms leading to cevostamab resistance in multiple myeloma

  Blood · 2025-11-03